Article tools

Author information

Find articles by
Salen, G. in:
JCI | PubMed | Google Scholar
Find articles by
Grundy, S. M. in:
JCI | PubMed | GoogleScholar

Published in Volume 52, Issue 11 (November,1973)
J. Clin. Invest. 52(11): 2822-2835 (1973). doi:10.1172/JCI107478.
Copyright © 1973, The American Society for Clinical Investigation

Articles

The Metabolism of Cholestanol, Cholesterol, and Bile Acids in Cerebrotendinous Xanthomatosis

Gerald Salen and Scott M. Grundy

^{Gastroenterology Section, New York Veterans Administration Hospital, Department of Medicine, New York University School of Medicine, New York 10010} ^{University of California, San Diego School of Medicine, La Jolla, California 92037}

Published November, 1973

The metabolism of cholesterol and its 5-dihydro derivative, cholestanol, was investigated by means of sterol balance and isotope kinetic techniques in 3 subjects with cerebrotendinous xanthomatosis (CTX) and 11 other individuals. All subjects were hospitalized on a metabolic ward and were fed diets practically free of cholesterol and cholestanol. After the intravenous administration of [1,2-³H]cholestanol, the radioactive sterol was transported and esterified in plasma lipoproteins in an identical manner to cholesterol. In these short-term experiments, the specific activity-time curves of plasma cholestanol conformed to two-pool models in both the CTX and control groups. However, cholestanol plasma concentrations, total body miscible pools, and daily synthesis rates were two to five times greater in the CTX than control individuals. The short-term specific activity decay curves of plasma [4-¹⁴C]cholesterol also conformed to two-pool models in both groups. However, in the CTX subjects the decay was more rapid, and daily cholesterol synthesis was nearly double that of the control subjects. Plasma concentrations and the sizes of the rapidly turning over pool of exchangeable cholesterol were apparently small in the CTX subjects, and these measurements did not correlate with the large cholesterol deposits found in tendon and tuberous xanthomas.

Despite active cholesterol synthesis, bile acid formation was subnormal in the CTX subjects. However, bile acid sequestration was accompanied by a rise in plasma cholestanol levels and greatly augmented fecal cholestanol outputs. In contrast, the administration of clofibrate lowered plasma cholesterol levels 50% and presumably reduced synthesis in the CTX subjects. Plasma cholesterol concentrations and fecal steroid excretion did not change significantly during this therapy.

These findings indicate that the excessive tissue deposits of cholesterol and cholestanol that characterize CTX were associated with hyperactive neutral sterol synthesis. The demonstration of subnormal bile acid formation suggests that defective bile acid synthesis may predispose to the neutral sterol abnormalities.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Copying, redistribution, and other usage policies

Articles that cite this article:

Human CYP7A1 deficiency: progress and enigmas
Anne Beigneux, Alan F. Hofmann, Stephen G. Young
J Clin Invest 110(1):29. doi:10.1172/JCI16076 [CrossRef]

Serum and hepatic cholestanol, squalene and noncholesterol sterols in man: A study on liver transplantation
Katriina Nikkilä, Krister Höckerstedt, Tatu A. Miettinen
Hepatol 15(5):863. doi:10.1002/hep.1840150519 [CrossRef]

Serum cholestanol, cholesterol precursors, and plant sterols during placebo-controlled treatment of primary biliary cirrhosis with ursodeoxycholic acid or colchicine
Tatu A. Miettinend, Martti Färkkilä, Matti Vuoristo, Anna-Liisa Karvonen, Rauli Leino, Juhani Lehtola, Claes Friman, Kari Seppälä, Juhani Tuominen
Hepatol 21(5):1261. doi:10.1002/hep.1840210508 [CrossRef]

Defects in Bile Acid Biosynthesis-Diagnosis and Treatment
Kenneth D. R. Setchell, James E. Heubi
JPGN Journal of Pediatric Gastroenterology and Nutrition 43(supplement 1):S17. doi:10.1097/01.mpg.0000226386.79483.7b [CrossRef]

Cholestanol Metabolism, Molecular Pathology, and Nutritional Implications
Yousuke Seyama
j med food 6(3):217. doi:10.1089/10966200360716634 [CrossRef]

Adult xanthogranulomatosis associated with abnormal plasma apolipoprotein levels
R. Bergman, R. Friedman-birnbaum, M. Aviram, I. Katz, H. Kerner, J.G. Brook
Clin Exp Dermatol 15(5):372. doi:10.1111/j.1365-2230.1990.tb02118.x [CrossRef]

Influence of increased membrane cholesterol on membrane fluidity and cell function in human red blood cells
Richard A. Cooper
J Supramol Struct 8(4):413. doi:10.1002/jss.400080404 [CrossRef]

Targeting bile-acid signalling for metabolic diseases
Charles Thomas, Roberto Pellicciari, Mark Pruzanski, Johan Auwerx, Kristina Schoonjans
Nat Rev Drug Discov 7(8):678. doi:10.1038/nrd2619 [CrossRef]

High cholestanol and low campesterol-to-sitosterol ratio in serum of patients with primary biliary cirrhosis before liver transplantation
Katriina Nikkilä, Krister Höckerstedt, Tatu A. Miettinen
Hepatol 13(4):663. doi:10.1002/hep.1840130409 [CrossRef]

Pregnancy in women with cerebrotendinous xanthomatosis (CTX): High risk condition for fetus and newborn infant?
V. M. Berginer, R. Carmi, G. Salen, John M. Opitz, James F. Reynolds
Am J Med Genet 31(1):11. doi:10.1002/ajmg.1320310104 [CrossRef]

Cerebrotendinous xanthomatosis: a defect in cellular sterol biosynthetic control
J. L. Barron, J. U. Maxwell, G. S. Rutherfoord
J Inherit Metab Dis 5(2):91. doi:10.1007/BF01799999 [CrossRef]

Cerebrotendinous xanthomatosis: A review of biochemical findings of the patient population in the netherlands
B. J. Koopman, B. G. Wolthers, J. C. Molen, W. Slik, R. J. Waterreus, A. Spreeken
J Inherit Metab Dis 11(1):56. doi:10.1007/BF01800057 [CrossRef]

Effects of cholestanol feeding and cholestyramine treatment on the tissue sterols in the rabbit
Marie S. Buchmann, Ole P. Clausen
Lipid 21(12):738. doi:10.1007/BF02535404 [CrossRef]

PEROXISOMES AND HUMAN METABOLIC DISEASES: THE CEREBROHEPATORENAL SYNDROME (CHRS), CEREBROTENDINOUS XANTHOMATOSIS, AND SCHILDER'S DISEASE (ADRENOLEUKODYSTROPHY)
Sidney Goldfischer
Ann N Y Acad Sci 386(1 peroxisomes a):526. doi:10.1111/j.1749-6632.1982.tb21470.x [CrossRef]

Bile Alcohols in Perspective
Norman B. Javitt
Hepatol 4(5):974. doi:10.1002/hep.1840040532 [CrossRef]

Formation and Metabolism of Bile Alcohols in Man
Georg Karlaganis, Jan SjÖvall
Hepatol 4(5):966. doi:10.1002/hep.1840040531 [CrossRef]

Accumulation of 7α-hydroxy-4-cholesten-3-one and cholesta-4,6-dien-3-one in patients with cerebrotendinous xanthomatosis: Effect of treatment with chenodeoxycholic acid
Ingemar Björkhem, Sverre Skrede, Marie S. Buchmann, Cara East, Scott Grundy
Hepatol 7(2):266. doi:10.1002/hep.1840070210 [CrossRef]

Oleic acid-induced cholelithiasis in the rabbit: Conversion of dietary oleic acid to cholestanol as a cause of calcium-bile salt gallstones
Sum P. Lee, Cliff Tasman-jones, Valerie F. Carlisle
Hepatol 7(3):529. doi:10.1002/hep.1840070319 [CrossRef]

Quantitative importance of the 25-hydroxylation pathway for bile acid biosynthesis in the rat
William C. Duane, Ingemar Björkhem, Jan Neal Hamilton, Susan M. Mueller
Hepatol 8(3):613. doi:10.1002/hep.1840080329 [CrossRef]

ADVANCES IN DERMATOLOGY?1974
R. K. Winkelmann
Australas J Dermatol 16(1):1. doi:10.1111/j.1440-0960.1975.tb00712.x [CrossRef]

Cerebrotendinous xanthomatosis: clinical and laboratory study of 2 cases
Horacio M. Canelas, Eder C. R. Quintão, Milberto Scaff, Karin S. Vasconcelos, Mario W. I. Brotto
Acta Neurol Scand 67(5):305. doi:10.1111/j.1600-0404.1983.tb04580.x [CrossRef]